Atezolizumab (atezo) vs chemotherapy (chemo) in patients (pts) with   platinum-treated locally advanced or metastatic urothelial carcinoma   (mUC): A long-term overall survival (OS) and safety update from the   phase III IMvigor211 study

Dokumenttyp:: Meeting Abstract
Autor(en):: Van der Heijden, M. S.; Loriot, Y.; Duran, I.; Ravaud, A.; Retz, M. M.; Vogelzang, N. J.; Nelson, B.; Wang, J.; Shen, X.; Powles, T.
Titel:: Atezolizumab (atezo) vs chemotherapy (chemo) in patients (pts) with platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): A long-term overall survival (OS) and safety update from the phase III IMvigor211 study
Zeitschriftentitel:: Ann Oncol
Jahr:: 2019
Band / Volume:: 30 Suppl 5
Print-ISSN:: 0923-7534
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: